ClinicalTrials.Veeva

Menu

A Study of Flt3-Ligand Levels in Sjögrens Syndrome

G

Göteborg University

Status

Completed

Conditions

Sjogrens Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT01470638
Flt3-L SS

Details and patient eligibility

About

The study aims to correlate levels of Flt3-ligand in Cerebrospinal Fluid (CSF) and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome.

Full description

The study aims to correlate levels of Flt3-ligand in CSF and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • fulfill the ACR-criteria for primary Sjogrens syndrome,
  • age above 18 years old

Exclusion criteria

  • other CNS-disease

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems